Patents Assigned to AxoGlia Therapeutics S.A.
  • Patent number: 7691900
    Abstract: The invention relates to any isolated or synthetic compound and, in particular, to compounds having formula which can: modulate the cell specification of neural stem cells, promote the differentiation and subsequent survival of differentiating glial cells and neurones, and promote the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes. In addition, the inventive compounds can reduce the inflammatory component of diseases that affect the nervous system, for example, by reducing activation of the microglia an/or astrocytes and/or by reducing reactive gliosis. The invention also relates to the methods of preparing such compounds and to the use of same in the preparation of a pharmaceutical composition that is intended for the prevention or treatment of diseases that affect the nervous system. More specifically, the inventive compounds have general formula.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: April 6, 2010
    Assignee: AxoGlia Therapeutics S.A.
    Inventors: Bang Luu, Paul Heuschling, Thierry Muller, Eleonora Morga